A later amendment corrects this filing, so the terms on this page may be out of date. See the latest version (2026-07-23) →
What happened
Neuromeka disclosed convertible bonds to raise US$101M, about 28.7% of its market value.
For context, this raise equals about 28.7% of the company's market value, which is the rough scale of potential new-share dilution.
| Instrument | Convertible bonds |
|---|---|
| Raise amount | US$101M |
| vs. market value | 28.7% |
| Filed | 2026-04-24, Material event report (paid-in and bonus issue) |
| Source | DART rcept 20260424000588 → open original filing |
Versions of this filing
- 2026-04-24Original (this page)
- 2026-06-02Amendment 1
- 2026-06-18Amendment 2
- 2026-07-23Amendment 3
Source: DART. Information only, not investment advice.